Sonoma Biotherapeutics
Prior to joining Sonoma, Brian worked at Orca Bio as a Manufacturing Associate. At Orca Bio, he manufactured allogeneic cell therapies for patients with diseased blood and immune system.
Brian has experience with isolating Tregs and earned a BS in Pharmaceutical Chemistry from UC Davis.
This person is not in the org chart
This person is not in any offices
Sonoma Biotherapeutics
1 followers
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.